| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology (C.S.V., N.R., C.Y., L.R.B., R.A.J.,
F.F.P.) Vanderbilt University Nashville, Tennessee
37232
Laboratory of Molecular Carcinogenesis (M.B.)
National Cancer Institute Bethesda, Maryland 20892
The estrogen receptor (ER) belongs to a family of ligand-inducible nuclear receptors that exert their effects by binding to cis-acting DNA elements in the regulatory region of target genes. The detailed mechanisms by which ER interacts with the estrogen response element (ERE) and affects transcription still remain to be elucidated. To study the ER-ERE interaction and transcription initiation, we employed purified recombinant ER expressed in both the baculovirus-Sf9 and his-tagged bacterial systems. The effect of high-mobility group (HMG) protein HMG-1 and purified recombinant TATA-binding protein-associated factor TAFII30 on ER-ERE binding and transcription initiation were assessed by electrophoretic mobility shift assay and in vitro transcription from an ERE-containing template (pERE2LovTATA), respectively. We find that purified, recombinant ER fails to bind to ERE in spite of high ligand-binding activity and electrophoretic and immunological properties identical to ER in MCF-7 breast cancer cells. HMG-1 interacts with ER and promotes ER-ERE binding in a concentration- and time-dependent manner. The effectiveness of HMG-1 to stimulate ER-ERE binding in the electrophoretic mobility shift assay depends on the sequence flanking the ERE consensus as well as the position of the latter in the oligonucleotide. We find that TAFII30 has no effect on ER-ERE binding either alone or in combination with ER and HMG-1. Although HMG-1 promotes ER-ERE binding, it fails to stimulate transcription initiation either in the presence or absence of hormone. In contrast, TAFII30, while not affecting ER-ERE binding, stimulates transcription initiation 20-fold in the presence of HMG-1. These results indicate that HMG-1 and TAFII30 act in sequence, the former acting to promote ER-ERE binding followed by the latter to stimulate transcription initiation.
This article has been cited by other articles:
![]() |
K. K. Hill, S. C. Roemer, D. N. M. Jones, M. E. A. Churchill, and D. P. Edwards A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain J. Biol. Chem., September 4, 2009; 284(36): 24415 - 24424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Roemer, J. Adelman, M. E. A. Churchill, and D. P. Edwards Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding Nucleic Acids Res., June 1, 2008; 36(11): 3655 - 3666. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Curtis, V. S. Likhite, I. X. McLeod, J. R. Yates, and A. M. Nardulli Interaction of the Tumor Metastasis Suppressor Nonmetastatic Protein 23 Homologue H1 and Estrogen Receptor {alpha} Alters Estrogen-Responsive Gene Expression Cancer Res., November 1, 2007; 67(21): 10600 - 10607. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Roemer, D. C. Donham, L. Sherman, V. H. Pon, D. P. Edwards, and M. E. A. Churchill Structure of the Progesterone Receptor-Deoxyribonucleic Acid Complex: Novel Interactions Required for Binding to Half-Site Response Elements Mol. Endocrinol., December 1, 2006; 20(12): 3042 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, X. Li, C. A. Maguire, R. Hilf, R. A. Bambara, and M. Muyan Binding of Estrogen Receptor {beta} to Estrogen Response Element in Situ Is Independent of Estradiol and Impaired by Its Amino Terminus Mol. Endocrinol., November 1, 2005; 19(11): 2696 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Das, R. C. Peterson, and W. M. Scovell High Mobility Group B Proteins Facilitate Strong Estrogen Receptor Binding to Classical and Half-Site Estrogen Response Elements and Relax Binding Selectivity Mol. Endocrinol., November 1, 2004; 18(11): 2616 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J. Lechago, A. Ertan, G. Ergun, R. Verm, M. Bridges, C. Johnson, K. Woods, F. Meriano, M. Chirala, et al. Expression of the High Mobility Group Proteins HMGI(Y) Correlates with Malignant Progression in Barrett's Metaplasia Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 30 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Amir, M. Barua, N. C. McKnight, S. Cheng, X. Yuan, and S. P. Balk A Direct {beta}-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4 J. Biol. Chem., August 15, 2003; 278(33): 30828 - 30834. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerjee and T. K. Kundu The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription Nucleic Acids Res., June 15, 2003; 31(12): 3236 - 3247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Crucitti, A. M. Abril, and M. Salas Bacteriophage Phi 29 Early Protein p17. SELF-ASSOCIATION AND HETERO-ASSOCIATION WITH THE VIRAL HISTONE-LIKE PROTEIN p6 J. Biol. Chem., February 7, 2003; 278(7): 4906 - 4911. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Melvin, S. C. Roemer, M. E. A. Churchill, and D. P. Edwards The C-terminal Extension (CTE) of the Nuclear Hormone Receptor DNA Binding Domain Determines Interactions and Functional Response to the HMGB-1/-2 Co-regulatory Proteins J. Biol. Chem., July 5, 2002; 277(28): 25115 - 25124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyamoto, M. Rahman, H. Takatera, H.-Y. Kang, S. Yeh, H.-C. Chang, K. Nishimura, N. Fujimoto, and C. Chang A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer Growth J. Biol. Chem., February 8, 2002; 277(7): 4609 - 4617. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yuan, M. L. Lu, T. Li, and S. P. Balk SRY Interacts with and Negatively Regulates Androgen Receptor Transcriptional Activity J. Biol. Chem., November 30, 2001; 276(49): 46647 - 46654. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. WANG, H. YANG, C. J. CZURA, A. E. SAMA, and K. J. TRACEY HMGB1 as a Late Mediator of Lethal Systemic Inflammation Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1768 - 1773. [Full Text] [PDF] |
||||
![]() |
C. J. Czura, Haichao Wang, and K. J. Tracey Dual roles for HMGB1: DNA binding and cytokine Innate Immunity, August 1, 2001; 7(4): 315 - 321. [Abstract] [PDF] |
||||
![]() |
K. B. Ellwood, Y.-M. Yen, R. C. Johnson, and M. Carey Mechanism for Specificity by HMG-1 in Enhanceosome Assembly Mol. Cell. Biol., June 15, 2000; 20(12): 4359 - 4370. [Abstract] [Full Text] |
||||
![]() |
C. K. Glass and M. G. Rosenfeld The coregulator exchange in transcriptional functions of nuclear receptors Genes & Dev., January 15, 2000; 14(2): 121 - 141. [Full Text] |
||||
![]() |
M. Elías-Arnanz and M. Salas Functional interactions between a phage histone-like protein and a transcriptional factor in regulation of phi 29 early-late transcriptional switch Genes & Dev., October 1, 1999; 13(19): 2502 - 2513. [Abstract] [Full Text] |
||||
![]() |
M. Bustin Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins Mol. Cell. Biol., August 1, 1999; 19(8): 5237 - 5246. [Full Text] [PDF] |
||||
![]() |
C. C. Zhang, S. Krieg, and D. J. Shapiro HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells Mol. Endocrinol., April 1, 1999; 13(4): 632 - 643. [Abstract] [Full Text] |
||||
![]() |
S. Um, M. Harbers, A. Benecke, B. Pierrat, R. Losson, and P. Chambon Retinoic Acid Receptors Interact Physically and Functionally with the T:G Mismatch-specific Thymine-DNA Glycosylase J. Biol. Chem., August 14, 1998; 273(33): 20728 - 20736. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Boonyaratanakornkit, V. Melvin, P. Prendergast, M. Altmann, L. Ronfani, M. E. Bianchi, L. Taraseviciene, S. K. Nordeen, E. A. Allegretto, and D. P. Edwards High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells Mol. Cell. Biol., August 1, 1998; 18(8): 4471 - 4487. [Abstract] [Full Text] |
||||
![]() |
L. E. Romine, J. R. Wood, L. A. Lamia, P. Prendergast, D. P. Edwards, and A. M. Nardulli The High Mobility Group Protein 1 Enhances Binding of the Estrogen Receptor DNA Binding Domain to the Estrogen Response Element Mol. Endocrinol., May 1, 1998; 12(5): 664 - 674. [Abstract] [Full Text] |
||||
![]() |
L. Jayaraman, N. C. Moorthy, K. G.K. Murthy, J. L. Manley, M. Bustin, and C. Prives High mobility group protein-1 (HMG-1) is a unique activator of p53 Genes & Dev., February 15, 1998; 12(4): 462 - 472. [Abstract] [Full Text] |
||||
![]() |
T. Imamura, H. Izumi, G. Nagatani, T. Ise, M. Nomoto, Y. Iwamoto, and K. Kohno Interaction with p53 Enhances Binding of Cisplatin-modified DNA by High Mobility Group 1 Protein J. Biol. Chem., March 2, 2001; 276(10): 7534 - 7540. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Das and W. M. Scovell The Binding Interaction of HMG-1 with the TATA-binding Protein/TATA Complex J. Biol. Chem., August 24, 2001; 276(35): 32597 - 32605. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |